Evidence map›Paper›PMID 25218541›Full record

ReviewThe Journal of thoracic and cardiovascular surgery2015

Use of genetics for personalized management of heritable thoracic aortic disease: how do we get there?

Dianna M Milewicz, Ellen S Regalado

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of thoracic and cardiovascular surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Guideline
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. New mechanistic insights to PLOD1-mediated human vascular disease.Translational research : the journal of laboratory and clinical medicine · 2022
    Article
  11. Increased Risk of Aortic Dissection with Perlecan Deficiency.International journal of molecular sciences · 2021
    Article
  12. Observational
  13. Article
  14. Review
  15. Human aortic aneurysm genomic dictionary: is it possible?Indian journal of thoracic and cardiovascular surgery · 2019
    Article
  16. Targeted genetic analysis in a large cohort of familial and sporadic cases of aneurysm or dissection of the thoracic aorta.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Article
  17. Article
  18. Article
  19. The 100 most-cited articles on aortic dissection.BMC cardiovascular disorders · 2017
    Article
  20. Genetic and Epigenetic Regulation of Aortic Aneurysms.BioMed research international · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Dianna M MilewiczJohn Ritter Research Program in Aortic and Vascular Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Tex. Electronic address: Dianna.M.Milewicz@uth.tmc.edu.
Ellen S RegaladoJohn Ritter Research Program in Aortic and Vascular Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Tex.
The University of Texas Health Science Center · USThe University of Texas Health Science Center at Houston · US

Funding

The Training CoreP50HL083794 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2006 to 2010
$11.3M
Genetic Predisposition To Thoracic Aortic Aneurysms/DissectionsR01HL109942 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2012 to 2023
$7.5M
Genetic Basis of Aortic Aneurysms/DissectionsR01HL062594 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2002 to 2009
$3.2M
NHLBI NIH HHS P50 HL083794NHLBI NIH HHS P50HL083794-01NHLBI NIH HHS R01 HL062594NHLBI NIH HHS R01 HL109942NHLBI NIH HHS R01 HL62594
6 · The paper itself

Abstract

The major diseases affecting the thoracic aorta are aortic aneurysms and acute aortic dissections. Medical treatments can slow the enlargement of aneurysms, but the mainstay of treatment to prevent premature death resulting from dissection is surgical repair of the thoracic aortic aneurysm, which is typically recommended when the aortic diameter reaches 5.0 to 5.5 cm. Studies of patients with acute aortic dissections, however, indicate that as many as 60% of dissections occur at aortic diameters smaller than 5.5 cm. Clinical predictors are therefore needed to distinguish those at risk for dissection at an aortic diameter smaller than 5.0 cm and to determine the aortic diameter that justifies the risk of surgical repair to prevent an acute aortic dissection. Data from genetic studies during the past decade have established that mutations in specific genes can distinguish patients at risk for the disease and predict the risk of early dissection at diameters smaller than 5.0 cm. This information has the potential to optimize the timing of aortic surgery to prevent acute dissections.

Indexed as

Genetic TestingAcute DiseaseAorta, ThoracicAortic Aneurysm, ThoracicAortic DissectionGenetic Predisposition to DiseaseHeredityHumansPatient SelectionPhenotypePrecision MedicinePredictive Value of TestsPrognosisRisk AssessmentRisk Factors

Identifiers

PMID25218541
PMCPMC4354949
OpenAlexW2080198556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.